News about Clinical Trials

3D model created for rare neuromuscular disorder

Scientists have created a bioengineered 3-D model that mimics the biology of two rare diseases. The researchers used the 'tissue chip' model to show how a drug could potentially treat the diseases, providing data for a drug company's FDA submission for authorization for clinical testing.

Clinical Trials | 04/05/2022 | By Sudeep Soparkar

New patent grant to OSE Immunotherapeutics by EPO

OSE Immunotherapeutics receives European patent covering novel myeloid immune checkpoint target, CLEC-1 for cancer treatment

Clinical Trials | 03/05/2022 | By Sudeep Soparkar

EMA reviews gene therapy for Haemophilia B

EMA (European Medicines Agency) has started reviewing the CSL Behring's MAA for gene therapy etranacogene dezaparvovec (EtranaDez), for the patients getting treatment for Haemophila B.

Clinical Trials | 28/04/2022 | By Sudeep Soparkar

ALS drug by Biogen and Ionis Pharmaceuticals fails in trials

Biogen and Ionis Pharmaceuticals were hoping to be the first to find a cure for ALS. That dream has now fizzled out with the companies calling it quits after receiving disappointing results from a phase 1 clinical trial.

Clinical Trials | 27/04/2022 | By Sudeep Soparkar

Anti-Tigit drug of Roche fails stage study

Roche's Genentech had disappointing news to share this week regarding its lung cancer hopeful.

Clinical Trials | 26/04/2022 | By Sudeep Soparkar

Funds of $130m raised for B cell medications

Be Bio raises $130m to foster designed B cell medications. As a feature of the financing, ARCH Venture Partners overseeing chief Steven Gillis will join Be Bio's governing body.

Clinical Trials | 23/04/2022 | By Sudeep Soparkar

BioXcel to develop drugs in oncology

BioXcel shapes entirely claimed auxiliary OnkosXcel to foster prescriptions centered in oncology

Clinical Trials | 21/04/2022 | By Sudeep Soparkar

IDB therapies to improve with lymphoid cell maturity

New knowledge on lymphoid cell maturity could lead to more effective IBD therapies

Clinical Trials | 18/04/2022 | By Sudeep Soparkar

Effects of rilzabrutinib in individuals with insusceptible thrombocytopenia

Positive phase 1/2 study results of rilzabrutinib in people with immune thrombocytopenia published in The New England Journal of Medicine

Clinical Trials | 16/04/2022 | By Sudeep Soparkar

Cryo-electron microscopy answers for help underlying science research

Thermo Fisher Scientific, the world innovator in serving science, as of late sent the cutting edge cryo-transmission electron magnifying lens at the Center for Cellular and Molecular Biology (CCMB), Hyderabad, Telangana. The office was inaugurated by Dr Shekhar Mande, chief general, Council of Scientific and Industrial Research (CSIR).

Clinical Trials | 13/04/2022 | By Sudeep Soparkar